$77.00
Deficient plasma for the assay of Factor XII. For US and Canada: For Research Only. Product details here.
PRODUCT DESCRIPTION
In US and Canada: For Research Use Only. Not for Use in Diagnostic Procedures. Deficient plasma for the assay of Factor XII. All the clotting factors are present (constant and in the normal range, brought by the deficient plasma), except for FXII, which is brought by the diluted tested plasma, and clotting is triggered with cephalin, activator and calcium (APTT). FXII is the limiting factor and clotting time is inversely proportional to the concentration of FXII.
Deficient plasma for the assay of Factor XII. For US and Canada: For Research Only. Product details here.
PRODUCT CHARACTERISTICS
Plasma deficient for FXII: < 1% Other coagulation factors: > 50%
PRODUCT COMPONENTS
Citrated human plasma, deficient for Factor XII, immuno-depleted, lyophilized in the presence of glycine and stabilizers.
PRODUCT APPLICATION
For measurement of Factor XII (FXII or Hageman Factor) activity in research applications.
For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
Associated calibrator and controls are available: BIOPHEN Plasma Calibrator (Ref A222101-RUO), BIOPHEN Normal Control Plasma
(Ref A223201-RUO) and BIOPHEN Abnormal Control Plasma (Ref A223301-RUO).
MSDS Documents
IFU Documents
